English

CUBIST PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2014-11-07

85 filing records in this dataset, filed from 1996-12-09 to 2014-11-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

309 million USD

2014 Q3 · USD

Exact inputs and evidence

Revenue: 309155000 USD Source

Operating margin

21.93%

2014 Q3 · %

Exact inputs and evidence

Operating Income: 67809000 USD Source
Revenue: 309155000 USD Source

Operating cash flow

43.2 million USD

2014 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 105790000 USD Source
Operating Cash Flow: 62545000 USD Source

Free cash flow

34.4 million USD

2014 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 105790000 USD Source
Operating Cash Flow: 62545000 USD Source
Capital Expenditure: 21070000 USD Source
Capital Expenditure: 12186000 USD Source

Cash and cash equivalents: 234 million USD 2014-09-30 Source
Exact value

233691000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 76 million shares 2014-09-30 Source
Exact value

76012863 shares

Reported share-count change

2.70% · 2 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

74011707 shares · 2013-09-30· Source
76012863 shares · 2014-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.16 billion USD

2013-10-01 – 2014-09-30

Exact inputs and evidence

Revenue: 299741000 USD · 2013-10-01 – 2013-12-31 Source
Revenue: 261233000 USD · 2014-01-01 – 2014-03-31 Source
Revenue: 294398000 USD · 2014-04-01 – 2014-06-30 Source
Revenue: 309155000 USD · 2014-07-01 – 2014-09-30 Source

Operating cash flow

151 million USD

2013-10-01 – 2014-09-30

Exact inputs and evidence

Operating cash flow: 16409000 USD · 2013-01-01 – 2013-12-31 Source
Operating cash flow: -28381000 USD · 2013-01-01 – 2013-09-30 Source
Operating cash flow: -26592000 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: 62545000 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: -26592000 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: 105790000 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: 62545000 USD · 2014-01-01 – 2014-06-30 Source

Capital expenditure

24.9 million USD

2013-10-01 – 2014-09-30

Exact inputs and evidence

Capital expenditure: 15509000 USD · 2013-01-01 – 2013-12-31 Source
Capital expenditure: 11691000 USD · 2013-01-01 – 2013-09-30 Source
Capital expenditure: 1884000 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 12186000 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 1884000 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 21070000 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 12186000 USD · 2014-01-01 – 2014-06-30 Source

Free cash flow

126 million USD

2013-10-01 – 2014-09-30

Exact inputs and evidence

Operating cash flow: 16409000 USD · 2013-01-01 – 2013-12-31 Source
Operating cash flow: -28381000 USD · 2013-01-01 – 2013-09-30 Source
Operating cash flow: -26592000 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: 62545000 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: -26592000 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: 105790000 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: 62545000 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 15509000 USD · 2013-01-01 – 2013-12-31 Source
Capital expenditure: 11691000 USD · 2013-01-01 – 2013-09-30 Source
Capital expenditure: 1884000 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 12186000 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 1884000 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 21070000 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 12186000 USD · 2014-01-01 – 2014-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2014-11-07.

Financial data available through: 2013-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2013-12-31
Operating income: 11 of 11 periods available· newest 2013-12-31
Net income: 8 of 11 periods available· newest 2010-12-31
Operating cash flow: 7 of 11 periods available· newest 2013-12-31
Capital expenditure: 7 of 11 periods available· newest 2013-12-31
Total assets: 11 of 11 periods available· newest 2013-12-31
Total liabilities: 11 of 11 periods available· newest 2013-12-31
Current assets: 11 of 11 periods available· newest 2013-12-31
Current liabilities: 11 of 11 periods available· newest 2013-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2013-12-31
long term debt: No compatible figures in this window
Shares outstanding: 5 of 11 periods available· newest 2013-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+13.8%

Prior period

USD 926.36 million

2012-01-01 – 2012-12-31
Current period

USD 1.05 billion

2013-01-01 – 2013-12-31

Exact inputs and evidence

1054442000 − 926359000 = 128083000 USD

926359000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
1054442000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CUBIST PHARMACEUTICALS INC · 2013-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Year-over-year change in Revenue: 128083000 USD Concept: fundies:Revenue Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1054442000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1723798 Filing: 000104746914001280 Input fundies:Revenue: 926359000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1723907 Filing: 000104746914001280
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-92.4%

Prior period

USD 215.65 million

2012-01-01 – 2012-12-31
Current period

USD 16.41 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

16409000 − 215650000 = -199241000 USD

215650000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
16409000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CUBIST PHARMACEUTICALS INC · 2013-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Year-over-year change in Operating cash flow: -199241000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 16409000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1734348 Filing: 000104746914001280 Input fundies:OperatingCashFlow: 215650000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1734563 Filing: 000104746914001280
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-14.5%

Prior period

USD 18.13 million

2012-01-01 – 2012-12-31
Current period

USD 15.51 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

15509000 − 18129000 = -2620000 USD

18129000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
15509000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CUBIST PHARMACEUTICALS INC · 2013-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Year-over-year change in Capital expenditure: -2620000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 15509000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#2517107 Filing: 000104746914001280 Input fundies:CapitalExpenditure: 18129000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1735175 Filing: 000104746914001280
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2013 2013-01-01 – 2013-12-31

Revenue USD 1.05 billion 100% of revenue
Cost of revenue USD 260.31 million 25% of revenue
Operating expenses USD 735.68 million 70% of revenue
Other operating costs Derived USD 32.04 million 3% of revenue
Operating income USD 26.41 million 2.5% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow USD 16.41 million 1.6% of revenue
Capital expenditure USD 15.51 million 1.5% of revenue
Free cash flow Derived USD 900,000 0.1% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2004 Operating loss: operating costs were 195% of revenue.
2005 Operating loss: operating costs were 121% of revenue.
2006 Net loss: net income was −0.2% of revenue.
2007 12%86%
2008 Net income was higher than operating income, so the split is not drawn.
2009 14%10%75%
2010 15%15%70%
2011 Not shown: operating income or net income is not reported.
2012 Not shown: operating income or net income is not reported.
2013 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2004 2004-01-01 – 2004-12-31	68071000	132684000 Derived	-64613000	11899000 Derived	-76512000	Unavailable	Source 2004-01-01 – 2004-12-31: 68071000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -64613000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -76512000 USD Inspect Net Income Open source
2005 2005-01-01 – 2005-12-31	120645000	146078000 Derived	-25433000	6419000 Derived	-31852000	Unavailable	Source 2005-01-01 – 2005-12-31: 120645000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -25433000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -31852000 USD Inspect Net Income Open source
2006 2006-01-01 – 2006-12-31	194748000	189832000 Derived	4916000	5292000 Derived	-376000	Unavailable	Source 2006-01-01 – 2006-12-31: 194748000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 4916000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -376000 USD Inspect Net Income Open source
2007 2007-01-01 – 2007-12-31	294620000	253182000 Derived	41438000	5842000 Derived	35596000	Unavailable	Source 2007-01-01 – 2007-12-31: 294620000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 41438000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 35596000 USD Inspect Net Income Open source
2008 2008-01-01 – 2008-12-31	433641000	342752000 Derived	90889000	-37003000 Derived	127892000	96856000 Derived	Source 2008-01-01 – 2008-12-31: 433641000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: 90889000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 127892000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 122192000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 25336000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	562144000	424384000 Derived	137760000	58160000 Derived	79600000	148658000 Derived	Source 2009-01-01 – 2009-12-31: 562144000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 137760000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 79600000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: 159765000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 11107000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	636458000	446859000 Derived	189599000	95274000 Derived	94325000	167000000 Derived	Source 2010-01-01 – 2010-12-31: 636458000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 189599000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 94325000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 184474000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 17474000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	753972000	621441000 Derived	132531000	Unavailable	Unavailable	100301000 Derived	Source 2011-01-01 – 2011-12-31: 753972000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 132531000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 200369000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 100068000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	926359000	689253000 Derived	237106000	Unavailable	Unavailable	197521000 Derived	Source 2012-01-01 – 2012-12-31: 926359000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: 237106000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 215650000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 18129000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	1054442000	1028032000 Derived	26410000	Unavailable	Unavailable	900000 Derived	Source 2013-01-01 – 2013-12-31: 1054442000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 26410000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 16409000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 15509000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.1B 2013

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Revenue	68071000	Revenue: 68071000 Open source
20052005-12-31	Revenue	120645000	Revenue: 120645000 Open source
20062006-12-31	Revenue	194748000	Revenue: 194748000 Open source
20072007-12-31	Revenue	294620000	Revenue: 294620000 Open source
20082008-12-31	Revenue	433641000	Revenue: 433641000 Open source
20092009-12-31	Revenue	562144000	Revenue: 562144000 Open source
20102010-12-31	Revenue	636458000	Revenue: 636458000 Open source
20112011-12-31	Revenue	753972000	Revenue: 753972000 Open source
20122012-12-31	Revenue	926359000	Revenue: 926359000 Open source
20132013-12-31	Revenue	1054442000	Revenue: 1054442000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

13.8% 2013

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Year over year	1,731.8%	Revenue: 68071000 Open source Revenue: 3716000 Open source
20052005-12-31	Year over year	77.2%	Revenue: 120645000 Open source Revenue: 68071000 Open source
20062006-12-31	Year over year	61.4%	Revenue: 194748000 Open source Revenue: 120645000 Open source
20072007-12-31	Year over year	51.3%	Revenue: 294620000 Open source Revenue: 194748000 Open source
20082008-12-31	Year over year	47.2%	Revenue: 433641000 Open source Revenue: 294620000 Open source
20092009-12-31	Year over year	29.6%	Revenue: 562144000 Open source Revenue: 433641000 Open source
20102010-12-31	Year over year	13.2%	Revenue: 636458000 Open source Revenue: 562144000 Open source
20112011-12-31	Year over year	18.5%	Revenue: 753972000 Open source Revenue: 636458000 Open source
20122012-12-31	Year over year	22.9%	Revenue: 926359000 Open source Revenue: 753972000 Open source
20132013-12-31	Year over year	13.8%	Revenue: 1054442000 Open source Revenue: 926359000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 2.5% 2013

Net margin 14.8% 2010

Free cash flow margin 0.1% 2013

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Operating margin	-94.9%	Operating Income: -64613000 Open source Revenue: 68071000 Open source
20052005-12-31	Operating margin	-21.1%	Operating Income: -25433000 Open source Revenue: 120645000 Open source
20062006-12-31	Operating margin	2.5%	Operating Income: 4916000 Open source Revenue: 194748000 Open source
20072007-12-31	Operating margin	14.1%	Operating Income: 41438000 Open source Revenue: 294620000 Open source
20082008-12-31	Operating margin	21%	Operating Income: 90889000 Open source Revenue: 433641000 Open source
20092009-12-31	Operating margin	24.5%	Operating Income: 137760000 Open source Revenue: 562144000 Open source
20102010-12-31	Operating margin	29.8%	Operating Income: 189599000 Open source Revenue: 636458000 Open source
20112011-12-31	Operating margin	17.6%	Operating Income: 132531000 Open source Revenue: 753972000 Open source
20122012-12-31	Operating margin	25.6%	Operating Income: 237106000 Open source Revenue: 926359000 Open source
20132013-12-31	Operating margin	2.5%	Operating Income: 26410000 Open source Revenue: 1054442000 Open source
20042004-12-31	Net margin	-112.4%	Net Income: -76512000 Open source Revenue: 68071000 Open source
20052005-12-31	Net margin	-26.4%	Net Income: -31852000 Open source Revenue: 120645000 Open source
20062006-12-31	Net margin	-0.2%	Net Income: -376000 Open source Revenue: 194748000 Open source
20072007-12-31	Net margin	12.1%	Net Income: 35596000 Open source Revenue: 294620000 Open source
20082008-12-31	Net margin	29.5%	Net Income: 127892000 Open source Revenue: 433641000 Open source
20092009-12-31	Net margin	14.2%	Net Income: 79600000 Open source Revenue: 562144000 Open source
20102010-12-31	Net margin	14.8%	Net Income: 94325000 Open source Revenue: 636458000 Open source
2011-12-31	Net margin	Not reported	Revenue: 753972000 Open source
2012-12-31	Net margin	Not reported	Revenue: 926359000 Open source
2013-12-31	Net margin	Not reported	Revenue: 1054442000 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 68071000 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 120645000 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 194748000 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 294620000 Open source
20082008-12-31	Free cash flow margin	22.3%	Revenue: 433641000 Open source Operating Cash Flow: 122192000 Open source Capital Expenditure: 25336000 Open source
20092009-12-31	Free cash flow margin	26.4%	Revenue: 562144000 Open source Operating Cash Flow: 159765000 Open source Capital Expenditure: 11107000 Open source
20102010-12-31	Free cash flow margin	26.2%	Revenue: 636458000 Open source Operating Cash Flow: 184474000 Open source Capital Expenditure: 17474000 Open source
20112011-12-31	Free cash flow margin	13.3%	Revenue: 753972000 Open source Operating Cash Flow: 200369000 Open source Capital Expenditure: 100068000 Open source
20122012-12-31	Free cash flow margin	21.3%	Revenue: 926359000 Open source Operating Cash Flow: 215650000 Open source Capital Expenditure: 18129000 Open source
20132013-12-31	Free cash flow margin	0.1%	Revenue: 1054442000 Open source Operating Cash Flow: 16409000 Open source Capital Expenditure: 15509000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 16.4M 2013

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Operating cash flow	Not reported	No source recorded
20052005-12-31	Operating cash flow	Not reported	No source recorded
20062006-12-31	Operating cash flow	Not reported	No source recorded
20072007-12-31	Operating cash flow	Not reported	No source recorded
20082008-12-31	Operating cash flow	122192000	Operating Cash Flow: 122192000 Open source
20092009-12-31	Operating cash flow	159765000	Operating Cash Flow: 159765000 Open source
20102010-12-31	Operating cash flow	184474000	Operating Cash Flow: 184474000 Open source
20112011-12-31	Operating cash flow	200369000	Operating Cash Flow: 200369000 Open source
20122012-12-31	Operating cash flow	215650000	Operating Cash Flow: 215650000 Open source
20132013-12-31	Operating cash flow	16409000	Operating Cash Flow: 16409000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 900K 2013

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Free cash flow	Unavailable	No source recorded
20052005-12-31	Free cash flow	Unavailable	No source recorded
20062006-12-31	Free cash flow	Unavailable	No source recorded
20072007-12-31	Free cash flow	Unavailable	No source recorded
20082008-12-31	Free cash flow	96856000	Operating Cash Flow: 122192000 Open source Capital Expenditure: 25336000 Open source
20092009-12-31	Free cash flow	148658000	Operating Cash Flow: 159765000 Open source Capital Expenditure: 11107000 Open source
20102010-12-31	Free cash flow	167000000	Operating Cash Flow: 184474000 Open source Capital Expenditure: 17474000 Open source
20112011-12-31	Free cash flow	100301000	Operating Cash Flow: 200369000 Open source Capital Expenditure: 100068000 Open source
20122012-12-31	Free cash flow	197521000	Operating Cash Flow: 215650000 Open source Capital Expenditure: 18129000 Open source
20132013-12-31	Free cash flow	900000	Operating Cash Flow: 16409000 Open source Capital Expenditure: 15509000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

55.7% 2013

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Liabilities / assets	90.3%	Total Liabilities: 195062000 Open source Total Assets: 215908000 Open source
20052005-12-31	Liabilities / assets	92.4%	Total Liabilities: 201466000 Open source Total Assets: 218065000 Open source
20062006-12-31	Liabilities / assets	90.8%	Total Liabilities: 398445000 Open source Total Assets: 439035000 Open source
20072007-12-31	Liabilities / assets	81.5%	Total Liabilities: 435813000 Open source Total Assets: 534515000 Open source
20082008-12-31	Liabilities / assets	48.9%	Total Liabilities: 336814000 Open source Total Assets: 689141000 Open source
20092009-12-31	Liabilities / assets	52.2%	Total Liabilities: 513042000 Open source Total Assets: 983685000 Open source
20102010-12-31	Liabilities / assets	53.1%	Total Liabilities: 751734000 Open source Total Assets: 1415157000 Open source
20112011-12-31	Liabilities / assets	57.5%	Total Liabilities: 1083658000 Open source Total Assets: 1883515000 Open source
20122012-12-31	Liabilities / assets	48.7%	Total Liabilities: 941637000 Open source Total Assets: 1932385000 Open source
20132013-12-31	Liabilities / assets	55.7%	Total Liabilities: 1751401000 Open source Total Assets: 3145132000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.8× 2013

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Current assets / current liabilities	4.2×	Current Assets: 122987000 Open source Current Liabilities: 29284000 Open source
20052005-12-31	Current assets / current liabilities	3.81×	Current Assets: 134220000 Open source Current Liabilities: 35216000 Open source
20062006-12-31	Current assets / current liabilities	9.7×	Current Assets: 338367000 Open source Current Liabilities: 34885000 Open source
20072007-12-31	Current assets / current liabilities	6.13×	Current Assets: 409279000 Open source Current Liabilities: 66783000 Open source
20082008-12-31	Current assets / current liabilities	6.54×	Current Assets: 533176000 Open source Current Liabilities: 81480000 Open source
20092009-12-31	Current assets / current liabilities	3.62×	Current Assets: 458499000 Open source Current Liabilities: 126788000 Open source
20102010-12-31	Current assets / current liabilities	6.75×	Current Assets: 1016243000 Open source Current Liabilities: 150644000 Open source
20112011-12-31	Current assets / current liabilities	4.13×	Current Assets: 1043337000 Open source Current Liabilities: 252385000 Open source
20122012-12-31	Current assets / current liabilities	4.48×	Current Assets: 1157050000 Open source Current Liabilities: 258518000 Open source
20132013-12-31	Current assets / current liabilities	2.8×	Current Assets: 870168000 Open source Current Liabilities: 310828000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2004 2004-01-01 – 2004-12-31	−USD 76.51 million Exact value Exact value: -76512000 USD 2004-01-01 – 2004-12-31: -76512000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CUBIST PHARMACEUTICALS INC · 2004-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Net Income: -76512000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -76512000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/0001104659-07-015597.txt#9876 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 31.85 million Exact value Exact value: -31852000 USD 2005-01-01 – 2005-12-31: -31852000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CUBIST PHARMACEUTICALS INC · 2005-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Net Income: -31852000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31852000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/0001047469-08-002102.txt#6109 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 376,000 Exact value Exact value: -376000 USD 2006-01-01 – 2006-12-31: -376000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CUBIST PHARMACEUTICALS INC · 2006-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Net Income: -376000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -376000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/0001047469-09-001970.txt#8799 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	USD 35.6 million Exact value Exact value: 35596000 USD 2007-01-01 – 2007-12-31: 35596000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CUBIST PHARMACEUTICALS INC · 2007-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Net Income: 35596000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 35596000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/0001047469-10-001533.txt#9628 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	USD 127.89 million Exact value Exact value: 127892000 USD 2008-01-01 – 2008-12-31: 127892000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CUBIST PHARMACEUTICALS INC · 2008-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Net Income: 127892000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 127892000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/0001047469-11-001194.txt#10104 The citation records this snapshot. The page link may show a newer release later.	USD 122.19 million Exact value Exact value: 122192000 USD 2008-01-01 – 2008-12-31: 122192000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CUBIST PHARMACEUTICALS INC · 2008-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Operating Cash Flow: 122192000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 122192000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746911001194/cbst-20101231.xml#36813 Filing: 000104746911001194 The citation records this snapshot. The page link may show a newer release later.	USD 25.34 million Exact value Exact value: 25336000 USD 2008-01-01 – 2008-12-31: 25336000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CUBIST PHARMACEUTICALS INC · 2008-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Capital Expenditure: 25336000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 25336000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746911001194/cbst-20101231.xml#37140 Filing: 000104746911001194 The citation records this snapshot. The page link may show a newer release later.	USD 96.86 million Calculation and evidence 122192000 − 25336000 USD Exact free cash flow: 96856000 USD 2008-01-01 – 2008-12-31: 122192000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 25336000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CUBIST PHARMACEUTICALS INC · 2008-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Free cash flow: 96856000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 122192000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746911001194/cbst-20101231.xml#36813 Filing: 000104746911001194 Input fundies:CapitalExpenditure: 25336000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746911001194/cbst-20101231.xml#37140 Filing: 000104746911001194 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	USD 79.6 million Exact value Exact value: 79600000 USD 2009-01-01 – 2009-12-31: 79600000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CUBIST PHARMACEUTICALS INC · 2009-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Net Income: 79600000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 79600000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/0001047469-11-001194.txt#10104 The citation records this snapshot. The page link may show a newer release later.	USD 159.77 million Exact value Exact value: 159765000 USD 2009-01-01 – 2009-12-31: 159765000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CUBIST PHARMACEUTICALS INC · 2009-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Operating Cash Flow: 159765000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 159765000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746912001597/cbst-20111231.xml#939027 Filing: 000104746912001597 The citation records this snapshot. The page link may show a newer release later.	USD 11.11 million Exact value Exact value: 11107000 USD 2009-01-01 – 2009-12-31: 11107000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CUBIST PHARMACEUTICALS INC · 2009-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Capital Expenditure: 11107000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11107000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746912001597/cbst-20111231.xml#724090 Filing: 000104746912001597 The citation records this snapshot. The page link may show a newer release later.	USD 148.66 million Calculation and evidence 159765000 − 11107000 USD Exact free cash flow: 148658000 USD 2009-01-01 – 2009-12-31: 159765000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 11107000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CUBIST PHARMACEUTICALS INC · 2009-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Free cash flow: 148658000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 159765000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746912001597/cbst-20111231.xml#939027 Filing: 000104746912001597 Input fundies:CapitalExpenditure: 11107000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746912001597/cbst-20111231.xml#724090 Filing: 000104746912001597 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	USD 94.33 million Exact value Exact value: 94325000 USD 2010-01-01 – 2010-12-31: 94325000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CUBIST PHARMACEUTICALS INC · 2010-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Net Income: 94325000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 94325000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/0001047469-11-001194.txt#10104 The citation records this snapshot. The page link may show a newer release later.	USD 184.47 million Exact value Exact value: 184474000 USD 2010-01-01 – 2010-12-31: 184474000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CUBIST PHARMACEUTICALS INC · 2010-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Operating Cash Flow: 184474000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 184474000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746913001765/cbst-20121231.xml#204337 Filing: 000104746913001765 The citation records this snapshot. The page link may show a newer release later.	USD 17.47 million Exact value Exact value: 17474000 USD 2010-01-01 – 2010-12-31: 17474000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CUBIST PHARMACEUTICALS INC · 2010-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Capital Expenditure: 17474000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17474000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746913001765/cbst-20121231.xml#204909 Filing: 000104746913001765 The citation records this snapshot. The page link may show a newer release later.	USD 167 million Calculation and evidence 184474000 − 17474000 USD Exact free cash flow: 167000000 USD 2010-01-01 – 2010-12-31: 184474000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 17474000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CUBIST PHARMACEUTICALS INC · 2010-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Free cash flow: 167000000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 184474000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746913001765/cbst-20121231.xml#204337 Filing: 000104746913001765 Input fundies:CapitalExpenditure: 17474000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746913001765/cbst-20121231.xml#204909 Filing: 000104746913001765 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	Unavailable Not reported for this period.	USD 200.37 million Exact value Exact value: 200369000 USD 2011-01-01 – 2011-12-31: 200369000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CUBIST PHARMACEUTICALS INC · 2011-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Operating Cash Flow: 200369000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 200369000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1734779 Filing: 000104746914001280 The citation records this snapshot. The page link may show a newer release later.	USD 100.07 million Exact value Exact value: 100068000 USD 2011-01-01 – 2011-12-31: 100068000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CUBIST PHARMACEUTICALS INC · 2011-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Capital Expenditure: 100068000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 100068000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1735350 Filing: 000104746914001280 The citation records this snapshot. The page link may show a newer release later.	USD 100.3 million Calculation and evidence 200369000 − 100068000 USD Exact free cash flow: 100301000 USD 2011-01-01 – 2011-12-31: 200369000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 100068000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CUBIST PHARMACEUTICALS INC · 2011-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Free cash flow: 100301000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 200369000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1734779 Filing: 000104746914001280 Input fundies:CapitalExpenditure: 100068000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1735350 Filing: 000104746914001280 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	Unavailable Not reported for this period.	USD 215.65 million Exact value Exact value: 215650000 USD 2012-01-01 – 2012-12-31: 215650000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CUBIST PHARMACEUTICALS INC · 2012-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Operating Cash Flow: 215650000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 215650000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1734563 Filing: 000104746914001280 The citation records this snapshot. The page link may show a newer release later.	USD 18.13 million Exact value Exact value: 18129000 USD 2012-01-01 – 2012-12-31: 18129000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CUBIST PHARMACEUTICALS INC · 2012-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Capital Expenditure: 18129000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18129000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1735175 Filing: 000104746914001280 The citation records this snapshot. The page link may show a newer release later.	USD 197.52 million Calculation and evidence 215650000 − 18129000 USD Exact free cash flow: 197521000 USD 2012-01-01 – 2012-12-31: 215650000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 18129000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CUBIST PHARMACEUTICALS INC · 2012-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Free cash flow: 197521000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 215650000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1734563 Filing: 000104746914001280 Input fundies:CapitalExpenditure: 18129000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1735175 Filing: 000104746914001280 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	Unavailable Not reported for this period.	USD 16.41 million Exact value Exact value: 16409000 USD 2013-01-01 – 2013-12-31: 16409000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CUBIST PHARMACEUTICALS INC · 2013-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Operating Cash Flow: 16409000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 16409000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1734348 Filing: 000104746914001280 The citation records this snapshot. The page link may show a newer release later.	USD 15.51 million Exact value Exact value: 15509000 USD 2013-01-01 – 2013-12-31: 15509000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CUBIST PHARMACEUTICALS INC · 2013-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Capital Expenditure: 15509000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15509000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#2517107 Filing: 000104746914001280 The citation records this snapshot. The page link may show a newer release later.	USD 900,000 Calculation and evidence 16409000 − 15509000 USD Exact free cash flow: 900000 USD 2013-01-01 – 2013-12-31: 16409000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 15509000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CUBIST PHARMACEUTICALS INC · 2013-12-31 CUBIST PHARMACEUTICALS INC (edgar:912183) Free cash flow: 900000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/912183?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 16409000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#1734348 Filing: 000104746914001280 Input fundies:CapitalExpenditure: 15509000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/912183/000104746914001280/cbst-20131231.xml#2517107 Filing: 000104746914001280 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

85 filings · 1,690 latest values · 1,690 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000912183, 912183, edgar:912183

Also known as CUBIST PHARMACEUTICALS INC

CUBIST PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Operating cash flow

Capital expenditure

Where revenue goes

2013 2013-01-01 – 2013-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation